Found: 53
Select item for more details and to access through your institution.
Effectiveness and Safety of Biological Therapies in Very Severe Plaque Psoriasis: A Real-Life Retrospective Study.
- Published in:
- Journal of Personalized Medicine, 2024, v. 14, n. 2, p. 186, doi. 10.3390/jpm14020186
- By:
- Publication type:
- Article
Monkeypox infection with perianal lesions, fever, and lymphadenopathy.
- Published in:
- International Journal of Dermatology, 2023, v. 62, n. 3, p. e142, doi. 10.1111/ijd.16437
- By:
- Publication type:
- Article
Impact of delay in follow‐up due to COVID‐19 pandemic on skin cancer progression: a real‐life experience from an Italian hub hospital.
- Published in:
- International Journal of Dermatology, 2021, v. 60, n. 7, p. 860, doi. 10.1111/ijd.15501
- By:
- Publication type:
- Article
Palmar nodules in a young woman with ulcerative colitis and enteropathic arthritis.
- Published in:
- International Journal of Dermatology, 2021, v. 60, n. 6, p. e214, doi. 10.1111/ijd.15307
- By:
- Publication type:
- Article
Skin cancers: how to balance the risks and benefits of surgery during COVID‐19 pandemic (a Northern Italy single‐center experience).
- Published in:
- International Journal of Dermatology, 2020, v. 59, n. 10, p. 1287, doi. 10.1111/ijd.15086
- By:
- Publication type:
- Article
Complicated coronavirus disease 2019 (COVID‐19) in a psoriatic patient treated with ixekizumab.
- Published in:
- International Journal of Dermatology, 2020, v. 59, n. 8, p. e267, doi. 10.1111/ijd.15008
- By:
- Publication type:
- Article
Atypical facial pustular folliculitis by Klebsiella pneumoniae: a case report.
- Published in:
- 2024
- By:
- Publication type:
- Case Study
Atypical facial pustular folliculitis by Klebsiella pneumoniae: a case report.
- Published in:
- 2024
- By:
- Publication type:
- Case Study
A severe psoriasis flare after COVID-19 treated with risankizumab: complete skin clearance after 16 weeks.
- Published in:
- Dermatology Reports, 2024, v. 16, n. 1, p. 16, doi. 10.4081/dr.2023.9722
- By:
- Publication type:
- Article
Anti-interleukin-17 and anti-interleukin-23 biologic drugs for genital psoriasis: a single-center retrospective comparative study.
- Published in:
- Dermatology Reports, 2023, v. 15, n. 3, p. 1, doi. 10.4081/dr.2023.9692
- By:
- Publication type:
- Article
Sub‐erythrodermic psoriasis successfully treated with bimekizumab: A case report.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 12, p. 1, doi. 10.1111/dth.15952
- By:
- Publication type:
- Article
Real life long‐term efficacy and safety of ixekizumab in moderate‐to‐severe psoriasis: A 192 weeks multicentric retrospective study—IL PSO (Italian landscape psoriasis).
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 8, p. 1, doi. 10.1111/dth.15608
- By:
- Publication type:
- Article
Apremilast for the treatment of palmo‐plantar non‐pustular psoriasis: A real‐life single‐center retrospective study.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 2, p. 1, doi. 10.1111/dth.15253
- By:
- Publication type:
- Article
Anti‐IL17 and anti‐IL23 biologic drugs for scalp psoriasis: A single‐center retrospective comparative study.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 2, p. 1, doi. 10.1111/dth.15228
- By:
- Publication type:
- Article
A fatal case of COVID‐19 infection presenting with an erythema multiforme‐like eruption and fever.
- Published in:
- Dermatologic Therapy, 2020, v. 33, n. 4, p. 1, doi. 10.1111/dth.13779
- By:
- Publication type:
- Article
Non‐complicated evolution of COVID‐19 infection in a patient with psoriasis and psoriatic arthritis during treatment with adalimumab.
- Published in:
- Dermatologic Therapy, 2020, v. 33, n. 4, p. 1, doi. 10.1111/dth.13708
- By:
- Publication type:
- Article
Brodalumab: A new way to inhibit IL‐17 in psoriasis.
- Published in:
- Dermatologic Therapy, 2020, v. 33, n. 3, p. 1, doi. 10.1111/dth.13403
- By:
- Publication type:
- Article
Use of biological drugs in patients with psoriasis and psoriatic arthritis in Italy: Results from the PSONG survey.
- Published in:
- Dermatologic Therapy, 2018, v. 31, n. 1, p. 1, doi. 10.1111/dth.12565
- By:
- Publication type:
- Article
Topical Pimecrolimus as a New Optional Treatment in Cutaneous Sarcoidosis of Lichenoid Type.
- Published in:
- Case Reports in Dermatological Medicine, 2014, p. 1, doi. 10.1155/2014/976851
- By:
- Publication type:
- Article
Real-life Effectiveness and Safety of Risankizumab in Moderate-to-severe Plaque Psoriasis: A 40-week Multicentric Retrospective Study.
- Published in:
- Acta Dermato-Venereologica, 2021, v. 101, n. 11, p. 1, doi. 10.2340/actadv.v101.283
- By:
- Publication type:
- Article
Effectiveness and safety of risankizumab in HIV patients with psoriasis: A case series.
- Published in:
- International Journal of STD & AIDS, 2024, v. 35, n. 1, p. 67, doi. 10.1177/09564624231199510
- By:
- Publication type:
- Article
S100A8/A9 in psoriatic plaques from patients with psoriatic arthritis.
- Published in:
- Journal of International Medical Research, 2016, v. 44, p. 33, doi. 10.1177/0300060515598900
- By:
- Publication type:
- Article
Long-term safety of etanercept in psoriasis: Retrospective study focused on infections.
- Published in:
- Journal of International Medical Research, 2016, v. 44, p. 58, doi. 10.1177/0300060515593252
- By:
- Publication type:
- Article
Suicide risk and psychiatric comorbidity in patients with psoriasis.
- Published in:
- Journal of International Medical Research, 2016, v. 44, p. 61, doi. 10.1177/0300060515593253
- By:
- Publication type:
- Article
Long-term treatment with adalimumab in psoriatic arthritis: serum adalimumab concentration, immunogenicity and the link with clinical response.
- Published in:
- Journal of International Medical Research, 2016, v. 44, p. 48, doi. 10.1177/0300060515593235
- By:
- Publication type:
- Article
Cutaneous toxicity of CAR T‐cell therapy: Case report of a bullous life‐threatening reaction.
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2023, v. 37, n. 6, p. e729, doi. 10.1111/jdv.18892
- By:
- Publication type:
- Article
Real‐life effectiveness of tildrakizumab in chronic plaque psoriasis: A 52‐week multicentre retrospective study—IL PSO (Italian landscape psoriasis).
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2023, v. 37, n. 1, p. 93, doi. 10.1111/jdv.18594
- By:
- Publication type:
- Article
Effectiveness of ixekizumab for the treatment of moderate‐to‐severe plaque psoriasis with involvement of difficult‐to‐treat areas: A 52‐week multicenter retrospective study.
- Published in:
- Journal of Dermatology, 2024, v. 51, n. 6, p. 839, doi. 10.1111/1346-8138.17115
- By:
- Publication type:
- Article
Unusual case of linear anetoderma in children.
- Published in:
- Journal of Dermatology, 2014, v. 41, n. 6, p. 552, doi. 10.1111/1346-8138.12361
- By:
- Publication type:
- Article
TP63 and TP73 in cancer, an unresolved "family" puzzle of complexity, redundancy and hierarchy.
- Published in:
- FEBS Letters, 2014, v. 588, n. 16, p. 2590, doi. 10.1016/j.febslet.2014.06.047
- By:
- Publication type:
- Article
Drug Survival of Upadacitinib and Predicting Factors of Discontinuation in Adult Patients Affected by Moderate-to-Severe Atopic Dermatitis: An Italian Multicenter Analysis.
- Published in:
- Journal of Clinical Medicine, 2024, v. 13, n. 2, p. 553, doi. 10.3390/jcm13020553
- By:
- Publication type:
- Article
Safety of Interleukin Inhibitors in Patients with Plaque Psoriasis and Neoplasm: A Retrospective Study from Two Referral Centers.
- Published in:
- Clinical Drug Investigation, 2023, v. 43, n. 10, p. 807, doi. 10.1007/s40261-023-01306-2
- By:
- Publication type:
- Article
Intra-Class Switch Among IL-23 Inhibitors for Plaque Psoriasis: Is It Worth It?
- Published in:
- Clinical Drug Investigation, 2023, v. 43, n. 5, p. 365, doi. 10.1007/s40261-023-01271-w
- By:
- Publication type:
- Article
Effectiveness and Safety of Upadacitinib in the Treatment of Moderate-Severe Atopic Dermatitis: A Multicentric, Prospective, Real-World, Cohort Study.
- Published in:
- Drugs in R&D, 2022, v. 22, n. 3, p. 245, doi. 10.1007/s40268-022-00396-1
- By:
- Publication type:
- Article
Practical Use of Upadacitinib in Patients with Severe Atopic Dermatitis in a Real-World Setting: A Systematic Review.
- Published in:
- Clinical, Cosmetic & Investigational Dermatology, 2024, v. 17, p. 593, doi. 10.2147/CCID.S329442
- By:
- Publication type:
- Article
Methotrexate-Induced Mucositis in a Patient With Angioimmunoblastic T-cell Lymphoma.
- Published in:
- Cutis, 2024, v. 113, n. 1, p. 1, doi. 10.12788/cutis.0956
- By:
- Publication type:
- Article
An interesting case of oedema and ulceration in red areas of tattoo.
- Published in:
- International Wound Journal, 2016, v. 13, n. 5, p. 1025, doi. 10.1111/iwj.12311
- By:
- Publication type:
- Article
An extrafacial amelanotic lentigo maligna of the leg: a case report.
- Published in:
- International Wound Journal, 2016, v. 13, n. 5, p. 1034, doi. 10.1111/iwj.12342
- By:
- Publication type:
- Article
Fingertip dermatitis: a spy for psoriasis.
- Published in:
- International Wound Journal, 2016, v. 13, n. 5, p. 1032, doi. 10.1111/iwj.12340
- By:
- Publication type:
- Article
Inflammatory reaction to brown pigment in a tattoo.
- Published in:
- International Wound Journal, 2016, v. 13, n. 5, p. 1045, doi. 10.1111/iwj.12397
- By:
- Publication type:
- Article
Localised pseudoepitheliomatous hyperplasia: unusual cutaneous reaction pattern to tattoo.
- Published in:
- International Wound Journal, 2016, v. 13, n. 2, p. 294, doi. 10.1111/iwj.12256
- By:
- Publication type:
- Article
A Multidisciplinary Approach Is Beneficial in Atopic Dermatitis.
- Published in:
- Dermatology & Therapy, 2024, v. 14, n. 6, p. 1443, doi. 10.1007/s13555-024-01185-1
- By:
- Publication type:
- Article
Baricitinib Improvement Across Regions in Atopic Dermatitis Patients with Baseline Body Surface Area up to 40% and Severe Itch.
- Published in:
- Dermatology & Therapy, 2024, v. 14, n. 6, p. 1561, doi. 10.1007/s13555-024-01171-7
- By:
- Publication type:
- Article
Management of Patients Affected by Moderate-to-Severe Atopic Dermatitis with JAK Inhibitors in Real-World Clinical Practice: An Italian Delphi Consensus.
- Published in:
- Dermatology & Therapy, 2024, v. 14, n. 4, p. 919, doi. 10.1007/s13555-024-01135-x
- By:
- Publication type:
- Article
Real-Life Effectiveness and Safety of Upadacitinib in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: A Single-Center 16-Week Study.
- Published in:
- Dermatology & Therapy, 2023, v. 13, n. 2, p. 651, doi. 10.1007/s13555-022-00882-z
- By:
- Publication type:
- Article
Secukinumab in Patients with Psoriasis and a Personal History of Malignancy: A Multicenter Real-Life Observational Study.
- Published in:
- Dermatology & Therapy, 2022, v. 12, n. 11, p. 2613, doi. 10.1007/s13555-022-00797-9
- By:
- Publication type:
- Article
Real-Life Effectiveness and Safety of Risankizumab in 131 Patients Affected by Moderate-to-Severe Plaque Psoriasis: A 52-Week Retrospective Study.
- Published in:
- Dermatology & Therapy, 2022, v. 12, n. 10, p. 2309, doi. 10.1007/s13555-022-00795-x
- By:
- Publication type:
- Article
Concomitant Pyoderma Gangrenosum-like and Amicrobial Pustulosis of the Folds: a Case Report.
- Published in:
- 2020
- By:
- Publication type:
- Letter
Safety of Biologic Therapies in Patients with Moderate-to-Severe Plaque Psoriasis and Concomitant Viral Hepatitis: A Monocentric Retrospective Study.
- Published in:
- Dermatology & Therapy, 2022, v. 12, n. 5, p. 1263, doi. 10.1007/s13555-022-00726-w
- By:
- Publication type:
- Article
Antiproliferative Effects of 1α-OH-vitD<sub>3</sub> in Malignant Melanoma: Potential Therapeutic implications.
- Published in:
- Scientific Reports, 2017, p. 40370, doi. 10.1038/srep40370
- By:
- Publication type:
- Article